United Guardian (UG) Change in Account Payables (2010 - 2026)
United Guardian's (UG) quarterly Change in Account Payables came in at $385210.0 in Q2 2026, up 931.13% year-over-year from $37358.0 in Q2 2025, and up 205.18% quarter-over-quarter from -$366247.0 in Q1 2026.
Analysis
United Guardian (UG) Change in Account Payables (2010 - 2026) Analysis & Trends
United Guardian has disclosed Change in Account Payables across 17 years of filings, most recently posting $385210.0 for Q2 2026.
- In Q2 2026, Change in Account Payables rose 931.13% year-over-year to $385210.0; the TTM figure through Jun 2026 stood at $84146.0 (up 6.88% YoY), while the FY2025 annual figure was $55788.0, down 80.8% from the prior year.
- Change in Account Payables came in at $385210.0 for Q2 2026 at United Guardian, up from -$366247.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $411093.0 in Q1 2023 to a low of -$366247.0 in Q1 2026.
- Average Change in Account Payables over 5 years is $4936.7, with a median of -$37414.5 recorded in 2022.
- Year-over-year, Change in Account Payables tumbled 687.46% in 2023 and jumped 1602.47% in 2024.
- Over 5 years, Change in Account Payables stood at -$66175.0 in 2022, then surged by 52.02% to -$31750.0 in 2023, then slumped by 177.8% to -$88201.0 in 2024, then soared by 367.37% to $235827.0 in 2025, then soared by 63.34% to $385210.0 in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were $385210.0 in Q2 2026, -$366247.0 in Q1 2026, and $235827.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.97 Bn | 622.21 Bn | 17.26 Bn | - |
| 2 | AbbVie | 441.24 Bn | 434.67 Bn | 12.70 Bn | - |
| 3 | Merck | 364.65 Bn | 357.51 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.30 Bn | 258.61 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.95 Bn | 147.25 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.29 Bn | 44.29 Bn | - | 5.03 Mn |
| 8 | Incyte | 25.27 Bn | 20.73 Bn | 1.57 Bn | 22.43 Mn |
| 9 | United Therapeutics | 21.44 Bn | 18.78 Bn | 683.80 Mn | - |
| 10 | United Guardian | 32.67 Mn | 23.07 Mn | 1.55 Mn | 385,210.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 385,210.00 |
| Mar 31, 2026 | -366,247.00 |
| Dec 31, 2025 | 235,827.00 |
| Sep 30, 2025 | -170,644.00 |
| Jun 30, 2025 | 37,358.00 |
| Mar 31, 2025 | -46,753.00 |
| Dec 31, 2024 | -88,201.00 |
| Sep 30, 2024 | 176,325.00 |
| Jun 30, 2024 | -81,771.00 |
| Mar 31, 2024 | 284,201.00 |
| Dec 31, 2023 | -31,750.00 |
| Sep 30, 2023 | 10,357.00 |
| Jun 30, 2023 | -285,666.00 |
| Mar 31, 2023 | 411,093.00 |
| Dec 31, 2022 | -66,175.00 |
| Sep 30, 2022 | -319,852.00 |
| Jun 30, 2022 | 48,627.00 |
| Mar 31, 2022 | -43,079.00 |
| Dec 31, 2021 | 323,736.00 |
| Sep 30, 2021 | 61,155.00 |